Maureen Doyle-Scharff, Ph.D., M.B.A., FACEHP is a visionary change agent who is an expert in brokering public-private partnerships that drive changes in the global healthcare ecosystem. Recently retired from Pfizer Inc, she spent nearly 25 years leading a cross-functional team focused on enabling healthcare communities to advance science and close gaps in care through independent and collaborative grants and partnerships. In addition, she spent the last few years leading Pfizer’s Institute of Translational Equitable Medicine (ITEM), focused on the science behind health disparities and translating new data and information to improve patient outcomes globally. She has worked in the fields of medical education, continuing professional development, grants, quality improvement and behavior/systems change in a variety of capacities for over 30 years. Her passion and current work focus on empowering health equity through education and innovation; bridging care gaps with evidence-based approaches; and driving sustainable change via collaborative partnerships.